ReviewRSC advances2026
Influence of polymer additives on the rheological properties of bitumens.
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It is important to incorporate polymers into bituminous binders to improve the quality and performance of asphalt. Currently, polymer-modified asphalt binders (PMBs) play an important role in road engineering. Polymer modifiers absorb the maltene fractions of bitumen and form a three-dimensional network within the binder. The service life of polymer-modified asphalt pavements is approximately 24% longer than that of conventional pavements. Polymer additives are used to improve the properties of bitumen, such as increasing its strength and resistance to loads and extreme temperatures. Common additives include elastomers such as styrene-butadiene-styrene (SBS) and styrene-butadiene rubber (SBR). Plastomers such as ethylene vinyl acetate (EVA) are also widely used. These additives improve the stiffness and high-temperature performance. These modifications create polymer-modified bitumen, which is used in road surfaces to prevent cracking, rutting, and other types of wear, especially in areas with heavy traffic or extreme climates. Some of the main types of polymer additives include SBS, a common elastomer that improves elasticity and flexibility, making asphalt more resistant to cracking and rutting, especially at high temperatures and under heavy loads, and EVA, a plastomer that gives bitumen stiffness and strength. Styrene-butadiene rubber (SBR) is another elastomer used to modify bitumen and exhibits properties similar to SBS. Crumb rubber is a recycled material obtained from waste tires and can be used as an alternative modifier. Other additives include ethylene-propylene copolymers and various polyalkyl methacrylates, although the latter materials sometimes have limited applicability. The advantages of polymer modification include increased durability (makes the asphalt pavement more resistant to wear), increased thermal stability (improves performance at both high temperatures (rutting) and low temperatures (cracking)), increased elasticity and recovery (improves flexibility, allowing the pavement to better withstand loads), and reduced maintenance requirements (extends the service life of the pavement). This paper provides a review of research studies on the use of polymer additives to improve the rheological properties of bitumen. Although numerous studies have investigated individual polymer modifiers to date, there is still no comprehensive comparative review examining the effects of different polymer classes on the rheological behavior, compatibility, and long-term performance of bitumen. Therefore, this review aims to provide a systematic and comparative evaluation of polymer additives used in bitumen modification.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.